Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drozdz

Showing results (441-450 of 463) with videos related to

Pageof 47
Sort By:
Nature Medicine|March 18, 2023
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trialOrly Vardeny, James C Fang, Akshay S Desai, et al.
European Journal of Heart Failure|June 22, 2016
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regionsMaria G Crespo-Leiro, Stefan D Anker, Aldo P Maggioni, et al.
Circulation|September 5, 2020
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HFKieran F Docherty, Pardeep S Jhund, Inder Anand, et al.
Kidney International|May 20, 2018
Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysisBetti Schaefer, Maria Bartosova, Stephan Macher-Goeppinger, et al.
Journal of the American College of Cardiology|February 18, 2022
Predictors of Left Main Coronary Artery Disease in the ISCHEMIA TrialRoxy Senior, Harmony R Reynolds, James K Min, et al.
American Heart Journal|August 2, 2017
Use of troponin assay 99th percentile as the decision level for myocardial infarction diagnosisAkshay Bagai, Karen P Alexander, Jeffrey S Berger, et al.
The New England Journal of Medicine|October 23, 2009
Strict blood-pressure control and progression of renal failure in children, Elke Wühl, Antonella Trivelli, et al.
European Heart Journal|June 3, 2021
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF studyEwa A Jankowska, Bridget-Anne Kirwan, Mikhail Kosiborod, et al.
Journal of the American Society of Nephrology : JASN|June 2, 2017
Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in ChildrenAgnes Trautmann, Sven Schnaidt, Beata S Lipska-Ziętkiewicz, et al.
Lancet (London, England)|November 16, 2020
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trialPiotr Ponikowski, Bridget-Anne Kirwan, Stefan D Anker, et al.
Pageof 47

Showing results (441-450 of 463) with videos related to

Sort By:
Pageof 47
Nature Medicine|March 18, 2023
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trialOrly Vardeny, James C Fang, Akshay S Desai, et al.
European Journal of Heart Failure|June 22, 2016
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regionsMaria G Crespo-Leiro, Stefan D Anker, Aldo P Maggioni, et al.
Circulation|September 5, 2020
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HFKieran F Docherty, Pardeep S Jhund, Inder Anand, et al.
Kidney International|May 20, 2018
Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysisBetti Schaefer, Maria Bartosova, Stephan Macher-Goeppinger, et al.
Journal of the American College of Cardiology|February 18, 2022
Predictors of Left Main Coronary Artery Disease in the ISCHEMIA TrialRoxy Senior, Harmony R Reynolds, James K Min, et al.
American Heart Journal|August 2, 2017
Use of troponin assay 99th percentile as the decision level for myocardial infarction diagnosisAkshay Bagai, Karen P Alexander, Jeffrey S Berger, et al.
The New England Journal of Medicine|October 23, 2009
Strict blood-pressure control and progression of renal failure in children, Elke Wühl, Antonella Trivelli, et al.
European Heart Journal|June 3, 2021
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF studyEwa A Jankowska, Bridget-Anne Kirwan, Mikhail Kosiborod, et al.
Journal of the American Society of Nephrology : JASN|June 2, 2017
Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in ChildrenAgnes Trautmann, Sven Schnaidt, Beata S Lipska-Ziętkiewicz, et al.
Lancet (London, England)|November 16, 2020
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trialPiotr Ponikowski, Bridget-Anne Kirwan, Stefan D Anker, et al.
Pageof 47